中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Information bottleneck based knowledge selection for commonsense reasoning 期刊论文
Information Sciences, 2024, 卷号: 660, 页码: 120134
作者:  Zhao Yang;  Yuanzhe Zhang;  Pengfei Cao;  Cao Liu;  Jiansong Chen;  Jun Zhao;  Kang Liu
Adobe PDF(1069Kb)  |  收藏  |  浏览/下载：52/18  |  提交时间：2024/05/30
Commonsense reasoning  Knowledge selection  Information bottleneck  KG-augmented model  
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie;  She, Yun-Lang;  Wang, Ting-Ting;  Yang, Yang;  Sun, Xi-Wen;  Belluomini, Lorenzo;  Watanabe, Satoshi;  Dong, Di;  Tian, Jie;  Xie, Dong
Adobe PDF(3742Kb)  |  收藏  |  浏览/下载：370/46  |  提交时间：2022/06/10
Tumor biomarkers  immunotherapy  lung neoplasms  programmed cell death 1 receptor (PD-1 receptor)  biostatistics  
Exploring the predictive value of additional peritumoral regions based on deep learning and radiomics: A multicenter study 期刊论文
MEDICAL PHYSICS, 2021, 页码: 12
作者:  Wu, Xiangjun;  Dong, Di;  Zhang, Lu;  Fang, Mengjie;  Zhu, Yongbei;  He, Bingxi;  Ye, Zhaoxiang;  Zhang, Minming;  Zhang, Shuixing;  Tian, Jie
Adobe PDF(3862Kb)  |  收藏  |  浏览/下载：743/373  |  提交时间：2021/05/06
deep learning  peritumor  radiomics  
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images 期刊论文
Theranostics, 2020, 卷号: 0, 期号: 0, 页码: 0
作者:  Tian, Panwen;  He, Bingxi;  Dong, Di;  Mu, Wei;  Liu, Kunqin;  Liu, Li;  Zeng, Hao;  Liu, Yujie;  Jiang, Lili;  Zhou, Ping;  Huang, Zhipei;  Li, Weimin;  Tian, Jie
Adobe PDF(1539Kb)  |  收藏  |  浏览/下载：324/126  |  提交时间：2020/10/25
PD-L1 expression  deep learning  computed tomography  immunotherapy  non-small cell lung cancer.